Compounds and methods for selective c-terminal labeling

US2023192761A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2023192761-A1
Application numberUS-202217837360-A
CountryUS
Kind codeA1
Filing dateJun 10, 2022
Priority dateJan 21, 2020
Publication dateJun 22, 2023
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to compounds and methods for selective C-terminal functionalization of peptides. In certain embodiments, the compounds have improved water-solubility, and are suitable for use in connection with peptide sequencing methodologies.

First claim

Opening claim text (preview).

1 - 110 . (canceled) 111 . A compound of Formula (XV): or a salt thereof, wherein P is a peptide; Y 2 comprises a moiety resulting from a click reaction with an azide group; L 5 is a linker or is absent; and Z 2 comprises one or more of polyethylene glycol, single-stranded DNA, double-stranded DNA, biotin, and streptavidin. 112 . The compound or salt of claim 111 , wherein Y 2 comprises a triazole. 113 . The compound or salt of claim 111 , wherein L 5 is a linker. 114 . The compound or salt of claim 113 , wherein the linker comprises a substituted or unsubstituted aliphatic chain, wherein one or more carbon atoms are optionally replaced by a heteroatom, an aryl, heteroaryl, cycloalkyl, or heterocyclyl moiety. 115 . The compound or salt of claim 113 , wherein the linker comprises polyethylene glycol (PEG). 116 . The compound or salt of claim 113 , wherein the linker comprises a peptide. 117 . The compound or salt of claim 111 , wherein Z 2 comprises polyethene glycol. 118 . The compound or salt of claim 111 , wherein Z 2 comprises single-stranded DNA. 119 . The compound or salt of claim 111 , wherein Z 2 comprises double-stranded DNA. 120 . The compound or salt of claim 111 , wherein Z 2 comprises biotin. 121 . The compound or salt of claim 111 , wherein Z 2 comprises streptavidin. 122 . The compound or salt of claim 111 , wherein P comprises 2-100 amino acid residues. 123 . The compound or salt of claim 111 , wherein P comprises 2-30 amino acid residues. 124 . A surface, on which the compound or salt of claim 111 is immobilized. 125 . The surface of claim 124 , wherein the surface is a chip. 126 . A method of selective N-functionalization of a peptide, comprising reacting a plurality of peptides of Formula (XI): or a salt thereof, wherein each P independently is a peptide having an N-terminal amine, with a compound of Formula (XII): under conditions comprising Cu 2+ , or a precursor thereof, and a buffer having a pH of 10-11; to obtain a plurality of ε-azido compounds of the Formula (XIIIb): or a salt thereof. 127 . The method of claim 126 , further comprising reacting the plurality of compounds of Formula (XIIIb), or a salt thereof, with a compound of Formula (XIV): R 6 -L 5 -Z 2    (XIV) wherein R 6 is a moiety comprising an alkyne or a strained alkene; L 5 is a linker or is absent; and Z 2 comprises one or more of polyethylene glycol, single-stranded DNA, double-stranded DNA, biotin, and streptavidin; to obtain a plurality of compounds of Formula (XV): or a salt thereof, wherein Y 2 comprises a moiety resulting from a click reaction with the azide moiety of Formula (XIIIb), or a salt thereof, and R 6 .

Assignees

Inventors

Classifications

  • C07K1/128Primary

    sequencing · CPC title

  • from bacteria · CPC title

  • by hydrolysis {, i.e. solvolysis in general} · CPC title

  • by filtration, ultrafiltration or reverse osmosis · CPC title

  • C07K1/1077Primary

    by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2023192761A1 cover?
The present disclosure relates to compounds and methods for selective C-terminal functionalization of peptides. In certain embodiments, the compounds have improved water-solubility, and are suitable for use in connection with peptide sequencing methodologies.
Who is the assignee on this patent?
Quantum Si Inc
What technology area does this patent fall under?
Primary CPC classification C07K1/128. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jun 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).